miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis
{{output}}
Background and objectives: MicroRNA-dependent regulation of hepatic lipid metabolism has been recognized recently as a key pathological mechanism contributing to the development of NAFLD. However, whether miR-32-5p (miR-32) plays... ...
